A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal Data

The goal of this observational study is to learn if combining information from CT scans, blood tests, and pathology reports can better predict how pancreatic cancer will progress. The main questions it aims to answer are: * Can combining these types of data more accurately estimate how long a person might survive? * Can it better predict the risk of recurrence? Participants will not have any extra tests or treatments. They will: * Allow researchers to collect information from their existing medical records (such as surgery reports, imaging, and lab results) * Receive a follow-up phone call for up to 3 years to share health updates（about every 3 months for the prospective cohort）.

NCT Number	NCT07561814
Lead Sponsor	Shanghai Zhongshan Hospital Collaborators: The First Affiliated Hospital of University of South China, First Affiliated Hospital Xi'an Jiaotong University
Conditions	Pancreatic Cancer
Enrollment	1,030 participants
Start Date	2025-12-09
Primary Completion	2029-07-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-02